Scholarlink

Background <p>Accurate preoperative prediction of isocitrate dehydrogenase (<i>IDH</i>) genotype in gliomas is crucial for treatment planning and prognostic evaluation. However, variability across imaging modalities and centers limits model generalization in clinical practice.</p> Purpose <p>We aimed to develop and evaluate a&#xa0;functionally guided fusion Vision Transformer (FGF-ViT) network for <i>IDH</i> genotype prediction in gliomas and to assess its generalization across multicenter datasets and incomplete multimodal inputs.</p> Methods <p>This retrospective multicenter study involved glioma patients from multiple institutions. In step&#xa0;1, four FGF-ViT networks were constructed using different modality combinations (conventional MRI [cMRI]; MRI + diffusion-weighted imaging [DWI]; cMRI + perfusion-weighted imaging [PWI]; cMRI + DWI + PWI), trained on a&#xa0;primary cohort, and tested on an independent external validation set. Step&#xa0;2 evaluated model generalization on additional multicenter datasets with variable modality availability. Models fused cMRI, DWI, and DSC-PWI features via transformer attention. Performance was assessed using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity.</p> Results <p>The FGF-ViT achieved robust <i>IDH</i> prediction with an AUC of 0.822 (95% CI: 0.666–0.977) in the independent external validation cohort. Its performance remained stable even with one missing functional modality.</p> Conclusion <p>The proposed FGF-ViT provides a&#xa0;clinically relevant multimodal imaging and generalizable framework for preoperative <i>IDH</i> genotype prediction in gliomas, enabling reliable application across centers and incomplete multimodal conditions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A functionally guided fusion Vision Transformer for predicting IDH status in gliomas: a multicenter study with external validation and incomplete multimodal evaluation

  • 期刊论文

  • 发表日期：

    2026年6月17日

查看全文
  • Han-Wen Zhang,
  • Jia-Hua Cai,
  • Xu-Mei Tang,
  • Chun Luo,
  • Yong-Qian Mo,
  • Fan Lin,
  • Yi Lei,
  • Yu-Li Wang,
  • Hong-Bo Zhang,
  • Biao Huang

摘要

Background

Accurate preoperative prediction of isocitrate dehydrogenase (IDH) genotype in gliomas is crucial for treatment planning and prognostic evaluation. However, variability across imaging modalities and centers limits model generalization in clinical practice.

Purpose

We aimed to develop and evaluate a functionally guided fusion Vision Transformer (FGF-ViT) network for IDH genotype prediction in gliomas and to assess its generalization across multicenter datasets and incomplete multimodal inputs.

Methods

This retrospective multicenter study involved glioma patients from multiple institutions. In step 1, four FGF-ViT networks were constructed using different modality combinations (conventional MRI [cMRI]; MRI + diffusion-weighted imaging [DWI]; cMRI + perfusion-weighted imaging [PWI]; cMRI + DWI + PWI), trained on a primary cohort, and tested on an independent external validation set. Step 2 evaluated model generalization on additional multicenter datasets with variable modality availability. Models fused cMRI, DWI, and DSC-PWI features via transformer attention. Performance was assessed using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity.

Results

The FGF-ViT achieved robust IDH prediction with an AUC of 0.822 (95% CI: 0.666–0.977) in the independent external validation cohort. Its performance remained stable even with one missing functional modality.

Conclusion

The proposed FGF-ViT provides a clinically relevant multimodal imaging and generalizable framework for preoperative IDH genotype prediction in gliomas, enabling reliable application across centers and incomplete multimodal conditions.